The invention relates to the field of molecular
pharmacology and biological
medicine, and particularly discloses a new application of a natural
flavonoid compound
baicalein as a
catalase direct activator and an application of the natural
flavonoid compound
baicalein in preparation of drugs for preventing and treating
oxidative stress related diseases. The invention proves that
baicalein is directly combined with
catalase and the
thermal stability and
hydrolysis resistance of the
catalase are enhanced through
cell thermal migration experiment (CETSA),
drug affinity reaction targeted stability technology (DARTS), molecular docking and other experiments. An enzymatic reaction experiment shows that baicalein can enhance catalase activity in a
dose-
dependent manner in a concentration range of 5-25 [mu] mol / L, and the efficiency of
catalytic decomposition of
hydrogen peroxide is improved. A free
fatty acid (FFA)-induced
hepatocyte lipid accumulation model is adopted for
cell experiment, and the result shows that by means of baicalein treatment, the activity of catalase in cells can be enhanced, the content of
lipid peroxidation product
malondialdehyde (MDA) can be reduced, meanwhile, the level of
triglyceride (TG) can be reduced, the effect is reversed by a catalase inhibitor aminotriazole, and the activity of the catalase in the cells can be improved. It is proved that baicalein can remove
hydrogen peroxide in cells by activating catalase activity,
oxidative stress injury is relieved, and then the process of the non-
alcoholic fatty liver disease (NAFLD) is delayed. The invention defines that baicalein can directly activate the activity of catalase, and the baicalein has an important application prospect in preparation of drugs for treating or preventing
oxidative stress related diseases such as NAFLD, type 2
diabetes mellitus and neurodegenerative diseases as a natural-source catalase activator.